The Biomarkers Market Share to Reach US$ 65.0 Billion By 2023

The report analyzes the biomarkers market by product, type, application, disease indication, and region. Consumable, services, and software are the main sub segments included in the by product segment. Due to lower price, consumables accounted for the largest share of the global biomarkers market in 2016.

The biomarkers market is projected to register a compound annual growth rate (CAGR) of 13.8% during the forecast period of 2016–2023. It is projected that the market will cross US$ 65.0 billion by 2023.

A glimpse of the report structure is provided in the report description available on the website.
https://www.marketresearchengine.com/reportdetails/biomarkers-market

A competitive landscape of the leading companies is provided with company summary, financial summary, business strategy and planning, SWOT analysis, and current developments. The key players profiled in the report are QIAGEN N.V. (Netherlands), PerkinElmer, Inc., Merck & Co, Inc., Bio-Rad Laboratories, Enzo Biochem, EKF Diagnostics Holdings plc, Meso Scale Diagnostics, LLC, Singulex, Inc., BioSims Technologies, Cisbio Bioassays, and Signosis, Inc.

The major applications of biomarkers are diagnostics development, drug discovery & development, personalized medicine, and disease risk assessment. In 2016, the application segment is estimated to be dominated by diagnostics accounting for the largest share. The use of biomarkers in the diagnostic process is increasing rapidly due to its more accurate results and factors such as increased occurrence of cancer, technologically developed biomarker products, personalized cancer treatments, and the need for early-stage cancer diagnosis are influencing the demand for biomarkers.

The high growth is due to the increasing use of biomarkers in diagnostic for accurate results, escalating number of CROs and low-cost clinical trials in developing countries, and large-scale R&D initiatives. However, high investment but the relatively low cost and benefit ratio, sample collection- and storage-related technical issues act as restraints of the market.

The type segment covers safety biomarker, efficacy biomarker, and validation biomarker. Efficacy biomarker is further segmented into pharmacodynamics, predictive, prognostic, and surrogate biomarkers. The safety biomarkers segment is estimated to command the largest share of the global biomarkers market. However, efficacy is projected to surpass the safety segment registering the highest CAGR during the forecast period.

The disease indication segment covers cancer, cardiovascular disorders, neurological disorders, and immunological disorders. The global biomarkers market in 2016 is estimated to be dominated by the cancer segment accounting for the largest share. This growth is primarily attributed to the rapid occurrence of cancer.

Request Free Sample Report: https://www.marketresearchengine.com/reportdetails/biomarkers-market

The report studies the biomarkers market in North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It further analyzes the major country level markets in each region.

Table of Contents

1 INTRODUCTION
2 Research Methodology
3 Executive Summary
4 Premium Insights
4.1 Biomarkers: Market Overview
4.2 Geographic Analysis: Biomarkers Market, By Product (2016)
4.3 Market, By Type, 2016 vs 2021
4.4 Market Size, By Application, 2016 vs 2021
4.5 Market, By Disease Indication, 2016 vs 2021
4.6 Market: Geographic Growth Opportunities
4.7 Life Cycle Analysis, By Region, 2016
5 Market Overview
6 Biomarkers Market, By Product
7 Biomarkers Market, By Type
8 Biomarkers Market, By Application
9 Biomarkers Market, By Disease Indication
10 Biomarkers Market, By Region
11 Competitive Landscape
12 Company Profiles
12.1 Qiagen N.V.
12.2 Perkinelmer, Inc.
12.3 Merck Millipore
12.4 Bio-Rad Laboratories, Inc.
12.5 Enzo Biochem, Inc.
12.6 EKF Diagnostics Holdings, Inc.
12.7 Meso Scale Diagnostics, LLC.
12.8 Biosims Technologies Sas
12.9 Cisbio Bioassays
12.10 Signosis, Inc.

About Us

Market Research Engine (MRE) is a next-generation provider of syndicated research, customized research, and consulting services. MRE’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each Market Research Engine’s research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

Media Contact

Company Name: Market Research Engine
Contact Person: John Bay
Email: john@marketresearchengine.com
Phone: +1-855-984-1862
Country: United States
Website: https://www.marketresearchengine.com/

Address: 3422 SW 15 Street, Suite #8942, Deerfield Beach, FL 33442, United States

This release was published on openPR.